Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Sirotti

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Seminars in Arthritis and Rheumatism|June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition diseaseNicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Seminars in Arthritis and Rheumatism|March 4, 2025
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Seminars in Arthritis and Rheumatism|March 14, 2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2022
Reliability and Diagnostic Accuracy of Radiography for the Diagnosis of Calcium Pyrophosphate Deposition: Performance of the Novel Definitions Developed by an International Multidisciplinary Working GroupSilvia Sirotti, Fabio Becce, Luca M Sconfienza, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2024
Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria CohortTristan Pascart, Augustin Latourte, Sara K Tedeschi, et al.
The Lancet. Rheumatology|January 22, 2024
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient levelSilvia Sirotti, Lene Terslev, Emilio Filippucci, et al.
Annals of the Rheumatic Diseases|June 9, 2026
Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)Georgios Filippou, Laura Pezzoni, Emilio Filippucci, et al.
Annals of the Rheumatic Diseases|July 26, 2023
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition diseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2023
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition DiseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Seminars in Arthritis and Rheumatism|June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition diseaseNicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Seminars in Arthritis and Rheumatism|March 4, 2025
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Seminars in Arthritis and Rheumatism|March 14, 2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2022
Reliability and Diagnostic Accuracy of Radiography for the Diagnosis of Calcium Pyrophosphate Deposition: Performance of the Novel Definitions Developed by an International Multidisciplinary Working GroupSilvia Sirotti, Fabio Becce, Luca M Sconfienza, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2024
Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria CohortTristan Pascart, Augustin Latourte, Sara K Tedeschi, et al.
The Lancet. Rheumatology|January 22, 2024
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient levelSilvia Sirotti, Lene Terslev, Emilio Filippucci, et al.
Annals of the Rheumatic Diseases|June 9, 2026
Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)Georgios Filippou, Laura Pezzoni, Emilio Filippucci, et al.
Annals of the Rheumatic Diseases|July 26, 2023
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition diseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2023
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition DiseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Pageof 4